USFDA approval

Tris Pharma receives USFDA approval for ONYDA XR, a liquid non-stimulant ADHD medication

Read more

Bristol Myers Squibb’s cell therapy gets USFDA nod for relapsed or refractory follicular lymphoma

Read more

Gland Pharma receives USFDA approval for Edaravone Injection

Read more

Penbraya approval sparks shift to pentavalent meningococcal vaccines in US: GlobalData

Read more

USFDA approves Prasugrel tablets by Lupin

Read more

Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release tablets

Read more

USFDA gives final nod to Zydus Lifesciences’ generic version of insomnia drug

Read more

US FDA approves TG Therapeutics’ multiple sclerosis drug

Read more

USFDA approves Roche’s lymphoma therapy

Read more

USFDA approves Alembic Pharma’s sANDA Pregabalin capsules

Read more